What are the Royal College of Obstetricians and Gynaecologists (RCOG) guidelines for interpreting and managing cardiotocography (CTG) traces?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

RCOG CTG Guidelines

I must note that the evidence provided does not contain actual RCOG (Royal College of Obstetricians and Gynaecologists) guidelines - instead, it primarily references American guidelines (NICHD/ACOG) from 2009. However, I can provide guidance based on the available evidence that references RCOG classification systems.

CTG Classification System

CTG traces should be classified into three categories: Normal, Suspicious (Abnormal), and Pathological, with management escalating based on category 1. This three-tier system aligns with both RCOG and NICHD frameworks referenced in the evidence.

Category I (Normal)

  • Normal baseline FHR (110-160 bpm)
  • Moderate baseline variability present
  • No late or variable decelerations
  • Accelerations may be present or absent
  • Management: Continue current monitoring 2

Category II (Suspicious/Indeterminate)

Features include any of the following:

  • Baseline FHR changes (bradycardia <110 bpm without absent variability, or tachycardia)
  • Minimal or absent baseline variability
  • Absence of accelerations
  • Recurrent variable decelerations with moderate variability
  • Prolonged decelerations (>2 minutes but <10 minutes)

Management approach:

  1. Consider discontinuing oxytocin
  2. Implement conservative measures (detailed below)
  3. Assess need for expedited delivery if abnormalities persist or worsen 2

Category III (Pathological)

Absent baseline FHR variability with any of:

  • Recurrent late decelerations
  • Recurrent variable decelerations
  • Bradycardia
  • OR sinusoidal pattern

Management: Discontinue oxytocin immediately and expedite delivery (operative vaginal or cesarean) 2

Understanding Deceleration Patterns

Early Decelerations

  • Mirror uterine contractions symmetrically
  • Nadir coincides with contraction peak
  • Rarely go below 100 bpm
  • Nearly always benign - no intervention needed 2

Variable Decelerations

  • Usually benign, related to cord compression
  • Common in second stage of labor
  • Atypical features suggest hypoxemia:
    • Late onset relative to contractions
    • Loss of shoulders
    • Slow recovery 2

Late Decelerations

  • Onset after contraction begins
  • Nadir occurs after contraction peak
  • Indicates uteroplacental insufficiency
  • May be subtle - use straight edge along baseline to detect 2
  • Always pathological and require intervention

Prolonged Decelerations

  • Duration: 2-10 minutes
  • Causes: head compression, cord compression, or uteroplacental insufficiency
  • Management depends on clinical context and other FHR features 2

Intrauterine Resuscitation Protocol

When CTG becomes suspicious or pathological, implement these interventions systematically:

  1. Change maternal position (left lateral preferred)
  2. Assess maternal vital signs (temperature, BP, pulse)
  3. Discontinue oxytocin infusion if running
  4. Initiate oxygen at 6-10 L/minute
  5. Perform vaginal examination - check for:
    • Cord prolapse
    • Rapid fetal descent
    • Vaginal bleeding (abruption)
  6. Give IV fluid bolus if not already administered
  7. Assess fetal pH via:
    • Fetal scalp stimulation
    • Acoustic stimulation
    • (Scalp pH sampling rarely used now)
  8. Consider amnioinfusion for recurrent moderate-severe variable decelerations
  9. Expedite delivery if abnormalities persist 2

Fetal Scalp Stimulation

If absent or minimal variability without spontaneous accelerations:

  • Perform scalp or acoustic stimulation
  • Presence of acceleration indicates fetal pH ≥7.20 2
  • Absence of acceleration warrants consideration for expedited delivery

Critical Pitfalls

High interobserver variability exists, particularly for:

  • Baseline variability assessment
  • Deceleration classification
  • Overall trace categorization 3

CTG has low positive predictive value:

  • Sensitivity for pH <7.20: only 42.9%
  • Specificity: 73.6%
  • Many "pathological" traces do not have actual acidemia 4

Therefore: Never rely on CTG in isolation - integrate with:

  • Maternal risk factors (pregestational diabetes, preeclampsia strongly associated with acidemia 4)
  • Clinical context
  • Stage of labor (severe decelerations less significant if delivery imminent 2)

Documentation Requirements

  • Regular review by physicians and nurses throughout labor
  • Ensure good quality tracing
  • Document all interventions and timing
  • Consider flow sheets/partograms
  • Obtain cord blood gases after any delivery with abnormal FHR tracing (pH <7.00 or base deficit >12 mmol/L indicates acute hypoxic event) 2

Amnioinfusion Benefits

For recurrent deep variable decelerations, amnioinfusion reduces:

  • Frequency of decelerations
  • Cesarean delivery rates
  • Apgar scores <7 at 5 minutes
  • Low cord arterial pH (<7.20)
  • Maternal and neonatal hospital stays >3 days 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.